Preparation method of rivaroxaban

A technology of rivaroxaban and organic solvents, applied in the field of medicine, can solve problems such as inability to carry out industrial production, incomplete substrate reaction, toxicity yield, etc., and achieve the effect of low cost, simple operation and high yield

Inactive Publication Date: 2014-10-08
TIANJIN WEIJIE PHARMA
View PDF16 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] In this method, the substrate 4-(4-aminophenyl)-3-morpholinone (II) reacts with 2-(chloromethyl)oxirane under reflux conditions under the action of isophthalic acid to generate the compound (XII), but because isophthalic acid is easy to form a salt with the substrate 4-(4-aminophenyl)-3-morpholinone (II), resulting in incomplete reaction of the substrate
In addition, when compound (XIV) is prepared from compound (XII), since N,N-dimethylformam

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of rivaroxaban
  • Preparation method of rivaroxaban
  • Preparation method of rivaroxaban

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0031] Example 1:

[0032] a) Preparation of 2-((2R)-2-hydroxy-3-{[4-(3-oxo-4-morpholinyl)phenyl]amino}propyl)-1H-isoindole-1,3 (2H)-Diketone (IV)

[0033] Add absolute ethanol (1.48kg) and process water (467g) to a 3L reaction flask, turn on the stirrer to stir, and then add 4-(4-aminophenyl)-3-morpholinone(II)(62.3) g) and 2-[(2S)-2-oxiranylmethyl]-1H-isoindole-1,3(2H)-2one (III) (65.9g), start heating to 70℃, After reacting for 4 hours, stop heating, cool to 35°C, filter with suction, rinse the solid with 90% ethanol (150g), pump the mother liquor back into the reaction flask, distill 1kg of solvent, and add 2-[(2S)- 2-Ethylene oxide methyl]-1H-isoindole-1,3(2H)-2one(III)(32.9g), heat to 70℃, react for 4 hours, stop heating, and cool to 30℃ , Suction filtration, the solid is rinsed with 90% ethanol (100g), the filtrate is treated as a waste liquid, the solids obtained by the two suction filtrations are combined and dried. 121.8 g of product was obtained, purity: 96%, melting...

Example Embodiment

[0041] Example 2:

[0042] a) Preparation of 2-((2R)-2-hydroxy-3-{[4-(3-oxo-4-morpholinyl)phenyl]amino}propyl)-1H-isoindole-1,3 (2H)-Diketone (IV)

[0043] Add absolute ethanol (1.48kg) and process water (467g) to a 3L reaction flask, turn on the stirrer to stir, and then add 4-(4-aminophenyl)-3-morpholinone(II)(62.3) g) and 2-[(2S)-2-oxiranylmethyl]-1H-isoindole-1,3(2H)-2one (III) (65.9g), start heating to 70℃, React for 4 hours, stop heating, cool to 25°C, filter with suction, rinse the solid with 90% ethanol (150g), pump the mother liquor back into the reaction flask, distill 1kg solvent, and add 2-[(2S)- 2-Ethoxyethylene methyl]-1H-isoindole-1,3(2H)-2one(III)(32.9g), heat to 70℃, react for 4 hours, stop heating, and cool to 35℃ , Suction filtration, the solid is rinsed with 90% ethanol (100g), the filtrate is treated as a waste liquid, the solids obtained by the two suction filtrations are combined and dried. 117.8 g of product was obtained, purity: 90%, melting point: 217°...

Example Embodiment

[0051] Example 3:

[0052] a) Preparation of 2-((2R)-2-hydroxy-3-{[4-(3-oxo-4-morpholinyl)phenyl]amino}propyl)-1H-isoindole-1,3 (2H)-Diketone (IV)

[0053] Add absolute ethanol (1.48kg) and process water (467g) to a 3L reaction flask, start stirring, and then add 4-(4-aminophenyl)-3-morpholinone (II) (62.3g) and 2-[(2S)-2-Ethoxyethylenemethyl]-1H-isoindole-1,3(2H)-2one(III)(65.9g), start heating to 70℃, and react for 4 hours , Stop heating, cool to 35℃, filter with suction, rinse the solid with 90% ethanol (150g), pump the mother liquor back into the reaction flask, distill 1kg of solvent, add 2-[(2S)-2-ring to it Oxyethylene methyl]-1H-isoindole-1,3(2H)-2one(III)(39.54g), heat to 70℃, react for 4 hours, stop heating, cool to 30℃, filter with suction , The solid was rinsed with 90% ethanol (100g), the filtrate was treated as a waste liquid, and the solid obtained by two suction filtration was combined and dried. 122.9 g of product was obtained, purity: 96%, melting point: 217°C...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Melting pointaaaaaaaaaa
Login to view more

Abstract

The invention discloses a preparation method of rivaroxaban. According to the preparation method, by taking 4-(4-aminophenyl)-3-morpholone (II) and 2-[(2S)-2-oxiranylmethyl]-1H-isoindazole-1,3(2H)-2 ketone (III) as starting materials, rivaroxaban is prepared through the ring-opening reaction between amine and epoxy, the ring-closing reaction of carbonyldiimidazole, the deprotection of ethanol amine and the butting reaction between amine and acyl chloride. The preparation method of the rivaroxaban, which is disclosed by the invention, is easy to operate, can prevent a toxic solvent or reagent from being used in the last-step production and therefore can obtain a high-purity product; in addition, the preparation method is high in yield, low in cost and suitable for industrial large-scale production.

Description

technical field [0001] The invention belongs to the technical field of medicine, in particular to a preparation method of rivaroxaban. Background technique [0002] Rivaroxaban, the English name is Rivaroxaban, the chemical name is 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl] -1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide, its structural formula is: [0003] [0004] Rivaroxaban is a highly selective oral drug that directly inhibits factor Xa developed by Bayer AG. Factor Xa is the intersection of extrinsic and intrinsic coagulation pathways, and is a key point in the coagulation process. Rivaroxaban is the first oral direct inhibitor of factor Xa, which can directly inhibit factor Xa in a free or bound state with high selectivity, produce anticoagulant effect, interrupt the endogenous and exogenous pathways of coagulation cascade, and inhibit coagulation Enzyme production and thrombosis. [0005] In view of the good market prospect of rivaroxaban, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D413/14
CPCC07D413/14
Inventor 宋洪海王兴锋黄海平林松
Owner TIANJIN WEIJIE PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap